According to filings with the U.S. Securities and Exchange Commission, Imperative Care is raising up to $100 Million in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Imperative Care
Imperative Care is a Silicon Valley-based medical technology company researching, developing and manufacturing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company is focused on addressing specific gaps in treatment and care to make an impact across the entire patient journey. Follow Imperative Care Stroke, and Imperative Care Vascular for updates.

To learn more about Imperative Care, visit https://imperativecare.com/
Imperative Care Linkedin Page: https://www.linkedin.com/company/imperativecare/

Contact:
Scott Elliott, Chief Legal Officer
408-502-7548
https://www.linkedin.com/in/scottdelliott/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.